@qantum,
Hi,
I am under the understanding that, the 310mm which u refer to is based on minimum orders collectively from the 6 contracts signed. However some contracts still have had no value put on them. Hikma and Sanofi collectively could triple that figure of 310 mm, in time to come.The drug delivery market is growing at a rapid rate annually , some segments of the market are even set to double up by 2016. Taking that into account and the market share that our signed partners already have, they could potentially be worth a $billion even more.not to forget the IP's for these products have no street value yet.
Please note the word potentially
Cheers
- Forums
- ASX - By Stock
- UNS
- 2014 contract outlook
2014 contract outlook, page-23
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)